000 | 01921 a2200541 4500 | ||
---|---|---|---|
005 | 20250518020104.0 | ||
264 | 0 | _c20190905 | |
008 | 201909s 0 0 eng d | ||
022 | _a2046-1402 | ||
024 | 7 |
_a10.12688/f1000research.16786.1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJakola, Asgeir Store | |
245 | 0 | 0 |
_aDisulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial. _h[electronic resource] |
260 |
_bF1000Research _c2018 |
||
300 |
_a1797 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCopper _xtherapeutic use |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 |
_aDisulfiram _xtherapeutic use |
650 | 0 | 4 | _aDrug Repositioning |
650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 | _aResearch Report |
650 | 0 | 4 | _aMulticenter Studies as Topic |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
700 | 1 | _aWerlenius, Katja | |
700 | 1 | _aMudaisi, Munila | |
700 | 1 | _aHylin, Sofia | |
700 | 1 | _aKinhult, Sara | |
700 | 1 | _aBartek, Jiri | |
700 | 1 | _aSalvesen, Øyvind | |
700 | 1 | _aCarlsen, Sven Magnus | |
700 | 1 | _aStrandéus, Michael | |
700 | 1 | _aLindskog, Magnus | |
700 | 1 | _aLöfgren, David | |
700 | 1 | _aRydenhag, Bertil | |
700 | 1 | _aCarstam, Louise | |
700 | 1 | _aGulati, Sasha | |
700 | 1 | _aSolheim, Ole | |
700 | 1 | _aBartek, Jiri | |
700 | 1 | _aSolheim, Tora | |
773 | 0 |
_tF1000Research _gvol. 7 _gp. 1797 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.12688/f1000research.16786.1 _zAvailable from publisher's website |
999 |
_c29258847 _d29258847 |